• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. ARROW PI CVC KIT: 3-L 7 FR X 20 CM AGB+; CATHETER,INTRAVASCULAR,THERAPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. ARROW PI CVC KIT: 3-L 7 FR X 20 CM AGB+; CATHETER,INTRAVASCULAR,THERAPE Back to Search Results
Catalog Number ASK-45703-PMST1
Device Problems Material Frayed (1262); Material Deformation (2976)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/11/2019
Event Type  malfunction  
Manufacturer Narrative
Qn#(b)(4).Medwatch received from the customer.No medwatch number provided.The risk manager reports that it is the consensus that the death of the patient was not caused by the issue with the guide wire.The medical examiner's results have not yet been received by the user facility.
 
Event Description
According to the medwatch "patient seen in the er for shortness of breath, her condition worsened.A central line was to be placed, the guidewire was kinked and noticed outside the body after it was introduced , and dilator was being placed by the er md.Everything was removed and attempted another site insertion with a second kit.Patient cardiac arrest and did not survive-unrelated to equipment".An interosseous line was in place for ketamine prior to central line placement.
 
Event Description
According to the medwatch "patient seen in the er for shortness of breath, her condition worsened.A central line was to be placed, the guidewire was kinked and noticed outside the body after it was introduced , and dilator was being placed by the er md.Everything was removed and attempted another site insertion with a second kit.Patient cardiac arrest and did not survive-unrelated to equipment".An interosseous line was in place for ketamine prior to central line placement.
 
Manufacturer Narrative
(b)(4).Complaint verification testing could not be performed as no sample was returned for analysis.A device history record review was performed and no relevant findings were identified.The instructions for use provided with the kit describes suggested techniques to minimize the likelihood of guide wire damage during use.It states that if resistance is encountered when attempting to remove the guide wire after catheter placement, the guide wire may be kinked about the tip of the catheter within the vessel.In this case it is recommended to withdraw the catheter relative to the guide wire about 2-3 cm and then attempt to remove the guide wire.The instructions caution that withdrawing the guide wire against the needle bevel or use of excessive force during removal could damage or break the wire.Without the device to evaluate the complaint could not be confirmed and the probable cause could not be determined from the available information.Teleflex will continue to monitor and trend for reports of this nature.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARROW PI CVC KIT: 3-L 7 FR X 20 CM AGB+
Type of Device
CATHETER,INTRAVASCULAR,THERAPE
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
MDR Report Key8443196
MDR Text Key139560627
Report Number1036844-2019-00226
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
K071538
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2019
Device Catalogue NumberASK-45703-PMST1
Device Lot Number23F18H0150
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/26/2019
Initial Date FDA Received03/22/2019
Supplement Dates Manufacturer Received04/11/2019
Supplement Dates FDA Received04/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
INTEROSSEOUS ACCESS LINE.; INTEROSSEOUS ACCESS LINE.; INTEROSSEOUS ACCESS LINE.
Patient Age45 YR
Patient Weight100
-
-